Author

Y. J. Oh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

A. R. Freels· 1 shared C. B. Lebrilla· 1 shared E.-J. Shin· 1 shared J. E. Oh· 1 shared J. H. Jun· 1 shared M. Dent· 1 shared M. L. Merchant· 1 shared N. Matoba· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. R. Freels

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Antitumor activity of a lectibody targeting cancer-associated high-mannose glycans

Y. J. Oh, M. Dent, A. R. Freels, Q. Zhou, C. B. Lebrilla, M. L. Merchant, N. Matoba

This study demonstrates that AvFc, a lectibody targeting high-mannose glycans, inhibits cancer cell migration and tumor growth in mice by blocking EGFR and IGF1R activation.

bioRxiv · Apr 28, 2021Cancer Biology

Renoprotective effects Of Dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats

S. H. Kim, J. H. Jun, J. E. Oh, E.-J. Shin, Y. J. Oh, Y. S. Choi

This study investigates the renoprotective effects of dexmedetomidine in diabetic rats with ischemia-reperfusion injury, finding that post-treatment is more effective than pre-treatment.

PLOS ONE · Aug 16, 2018Peer-reviewedPharmacology & Toxicology